Literature DB >> 25587619

Markers of endothelial dysfunction in patients with non-alcoholic fatty liver disease and coronary artery disease.

Elzafir Elsheikh, Zahra Younoszai, Munkhzul Otgonsuren, Sharon Hunt, Bryan Raybuck, Zobair M Younossi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25587619     DOI： 10.1111/jgh.12549

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN： 0815-9319            Impact factor:   4.029


× No keyword cloud information.
  9 in total

1.  Association between nonalcoholic fatty liver disease and carotid atherosclerosis: a meta-analysis.

Authors:  Jia Cai; Shujun Zhang; Wenxiang Huang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

2.  Correlation between non-alcoholic fatty liver with metabolic risk factors and brachial-ankle pulse wave velocity.

Authors:  Wen-Hua Zhu; Li-Zheng Fang; Chong-Rong Lu; Hong-Lei Dai; Jian-Hua Chen; Qiao-Hua Qiao; Li-Ying Chen
Journal:  World J Gastroenterol       Date:  2015-09-21       Impact factor: 5.742

3.  Is endocan a novel potential biomarker of liver steatosis and fibrosis?

Authors:  Aleksandra Klisić; Nebojša Kavarić; Ludovico Abenavoli; Verica Stanišić; Vesna Spasojević-Kalimanovska; Jelena Kotur-Stevuljević; Ana Ninić
Journal:  J Med Biochem       Date:  2020-09-02       Impact factor: 3.402

Review 4.  Vascular Endothelial Regulation of Obesity-Associated Insulin Resistance.

Authors:  Manna Li; Ming Qian; Jian Xu
Journal:  Front Cardiovasc Med       Date:  2017-08-09

Review 5.  Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: Current Issues and Future Perspectives in Preclinical and Clinical Research.

Authors:  Clarissa Berardo; Laura Giuseppina Di Pasqua; Marta Cagna; Plinio Richelmi; Mariapia Vairetti; Andrea Ferrigno
Journal:  Int J Mol Sci       Date:  2020-12-17       Impact factor: 5.923

Review 6.  Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications.

Authors:  Doris Ogresta; Anna Mrzljak; Maja Cigrovski Berkovic; Ines Bilic-Curcic; Sanja Stojsavljevic-Shapeski; Lucija Virovic-Jukic
Journal:  J Clin Transl Hepatol       Date:  2022-01-12

Review 7.  New Insights into Non-Alcoholic Fatty Liver Disease and Coronary Artery Disease: The Liver-Heart Axis.

Authors:  Georgiana-Diana Cazac; Cristina-Mihaela Lăcătușu; Cătălina Mihai; Elena-Daniela Grigorescu; Alina Onofriescu; Bogdan-Mircea Mihai
Journal:  Life (Basel)       Date:  2022-08-04

8.  Inhibition of HMGB1 release via salvianolic acid B-mediated SIRT1 up-regulation protects rats against non-alcoholic fatty liver disease.

Authors:  Wenjing Zeng; Wen Shan; Lili Gao; Dongyan Gao; Yan Hu; Guangzhi Wang; Ning Zhang; Zhenlu Li; Xiaofeng Tian; Wei Xu; Jinyong Peng; Xiaochi Ma; Jihong Yao
Journal:  Sci Rep       Date:  2015-11-03       Impact factor: 4.379

9.  Transcriptional Dynamics of Hepatic Sinusoid-Associated Cells After Liver Injury.

Authors:  Sofie M Bendixen; Daniel Hansen; Mike K Terkelsen; Emma A H Scott; Andreas F Moeller; Ronni Nielsen; Susanne Mandrup; Anders Schlosser; Thomas L Andersen; Grith L Sorensen; Aleksander Krag; Kedar N Natarajan; Sönke Detlefsen; Henrik Dimke; Kim Ravnskjaer
Journal:  Hepatology       Date:  2020-10-20       Impact factor: 17.298
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.